Litcius/Paper detail

Point-of-Care Antigen Test for SARS-CoV-2 in Asymptomatic College Students

Sarah C. Tinker, Christine M. Szablewski, Anastasia P. Litvintseva, Cherie Drenzek, Gary E. Voccio, Melissa A. Hunter, Steve Briggs, Debbie E. Heida, Jennifer Folster, Patricia L. Shewmaker, Magdalena Medrzycki, Michael D. Bowen, Caitlin Bohannon, Dennis A. Bagarozzi, Marla Petway, Paul A. Rota, Wendi Kuhnert-Tallman, Natalie J. Thornburg, Jessica L. Prince-Guerra, Lisa C. Barrios, Azaibi Tamin, Jennifer L. Harcourt, Margaret A. Honein, CDC Sample Collection Team,1

2021Emerging infectious diseases18 citationsDOIOpen Access PDF

Abstract

We used the BinaxNOW COVID-19 Ag Card to screen 1,540 asymptomatic college students for severe acute respiratory syndrome coronavirus 2 in a low-prevalence setting. Compared with reverse transcription PCR, BinaxNOW showed 20% overall sensitivity; among participants with culturable virus, sensitivity was 60%. BinaxNOW provides point-of-care screening but misses many infections.

Topics & Concepts

AsymptomaticMedicineCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Point of careCoronavirusAntigenVirologyInternal medicineImmunologyPathologyInfectious disease (medical specialty)DiseaseSARS-CoV-2 detection and testingBiosensors and Analytical DetectionCOVID-19 diagnosis using AI
Point-of-Care Antigen Test for SARS-CoV-2 in Asymptomatic College Students | Litcius